Dihydrofolate Reductase as a Target for Chemotherapy in Parasites

E-ISSN： 1873-4286|13|6|609-639

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.6, 2007-02, pp. : 609-639

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dihydrofolate reductase inhibitors: new developments in antiparasitic chemotherapy

By Savel Jean Durand Rémy

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1285-1290

Informa Healthcare

Access to resources Recommend Favorite

Challenges of Target/Compound Data Integration from Disease to Chemistry: A Case Study of Dihydrofolate Reductase Inhibitors

Current Drug Discovery Technologies, Vol. 2, Iss. 2, 2005-06 ,pp. : 75-87

Bentham Science Publishers

Access to resources Recommend Favorite

Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase

By Zuccotto F. Zvelebil M. Brun R. Chowdhury S.F. Di Lucrezia R. Leal I. Maes L. Ruiz-Perez L.M. Gonzalez Pacanowska D. Gilbert I.H.

European Journal of Medicinal Chemistry, Vol. 36, Iss. 5, 2001-05 ,pp. : 395-405

Elsevier

Access to resources Recommend Favorite

The Plant-Type Ferredoxin-NADP+ Reductase/Ferredoxin Redox System as a Possible Drug Target Against Apicomplexan Human Parasites

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3159-3172

Bentham Science Publishers

Access to resources Recommend Favorite

Virulence as a target for antimicrobial chemotherapy

By Alksne Lefa E

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 8, 2002-08 ,pp. : 1149-1159

Informa Healthcare

Access to resources Recommend Favorite